President Obama calls for increased investment in science, including biomedical research
In his State of the Union address, President Barack Obama presented the nation with a vision of a better future through investment in education, infrastructure, and research. Recognizing the role that innovation has played in this nation's history and the promise that it holds for addressing the many challenges we face, he stated that "maintaining our leadership in research and technology is crucial to America's success."
William T. Talman, MD, President of the Federation of American Societies for Experimental Biology (FASEB) responded, "we wholeheartedly agree with the President's emphasis on education and research. We are especially pleased to hear that he will make investment in biomedical research a priority in his 2012 budget. This will promote innovation, create new technologies, improve health, and revitalize the economy. It is also gratifying to the thousands of young Americans who have dedicated themselves to pursuit of careers in science and engineering, and this will inspire others to follow their lead. They will know that the nation values their contributions."
Talman also praised the President's emphasis on basic research, which recognized the irreplaceable role of public funding for the investigation of fundamental scientific principles. "This work leads to dramatic breakthroughs but does not receive sufficient support from the private sector because its applications are not always immediately apparent. FASEB will enthusiastically support President Obama's vision," Talman added.
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.